Abacavir, didanosine and tenofovir do not induce inflammatory, apoptotic or oxidative stress genes in coronary endothelial cells

Chul Kim, Samir Gupta, Linden Green, Brian M. Taylor, Maja Deuter-Reinhard, Zeruesenay Desta, Matthias Clauss

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: The use of abacavir and didanosine in HAART has been associated with an increased risk of myocardial infarction in HIV-infected patients. The aim of this study was to address the development of endothelial dysfunction in cultivated coronary artery endothelial cells (HCAECs) in response to abacavir, didanosine and tenofovir. We examined the impact of these drugs on the expression levels of the proinflammatory, oxidative stress and apoptosis regulating genes in HCAECs. Methods: We tested gene and protein expression changes in HCAECs in response to abacavir, didanosine and tenofovir using quantitative real-time reverse transciptase PCR, FACS and ELISA. The assessed genes/proteins included the proinflammatory molecules VCAM-1, ICAM-1, MCP-1, RANTES and IL-6. In addition, we assessed the gene expression of the intracellular reactive oxygen producing NADPH oxidase subunit gp91 PHOX and the apoptosis regulating molecules Bcl-2 and BAD. Results: Exposure of HCAECs to abacavir, didanosine and tenofovir resulted in no statistically significant changes in any of the tested genes/proteins at any time point or at any concentration. Conclusions: We found no evidence that abacavir, didanosine or tenofovir had direct in vitro effects on coronary endothelial cell gene transcription and protein expression of the selected mediators. If abacavir or didanosine increase cardiovascular risk, it is likely not through the direct endothelial activation pathways tested in these experiments. However, further studies are needed to completely exclude the toxicity of abacavir or didanosine on endothelial cells.

Original languageEnglish
Pages (from-to)1335-1339
Number of pages5
JournalAntiviral Therapy
Volume16
Issue number8
DOIs
StatePublished - 2011

Fingerprint

Tenofovir
Didanosine
Oxidative Stress
Endothelial Cells
Genes
Proteins
Apoptosis
Gene Expression
Chemokine CCL5
Vascular Cell Adhesion Molecule-1
NADPH Oxidase
Highly Active Antiretroviral Therapy
Intercellular Adhesion Molecule-1
abacavir
Interleukin-6
Coronary Vessels

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Abacavir, didanosine and tenofovir do not induce inflammatory, apoptotic or oxidative stress genes in coronary endothelial cells. / Kim, Chul; Gupta, Samir; Green, Linden; Taylor, Brian M.; Deuter-Reinhard, Maja; Desta, Zeruesenay; Clauss, Matthias.

In: Antiviral Therapy, Vol. 16, No. 8, 2011, p. 1335-1339.

Research output: Contribution to journalArticle

@article{3b38870866004cb4a65d2ca41205de80,
title = "Abacavir, didanosine and tenofovir do not induce inflammatory, apoptotic or oxidative stress genes in coronary endothelial cells",
abstract = "Background: The use of abacavir and didanosine in HAART has been associated with an increased risk of myocardial infarction in HIV-infected patients. The aim of this study was to address the development of endothelial dysfunction in cultivated coronary artery endothelial cells (HCAECs) in response to abacavir, didanosine and tenofovir. We examined the impact of these drugs on the expression levels of the proinflammatory, oxidative stress and apoptosis regulating genes in HCAECs. Methods: We tested gene and protein expression changes in HCAECs in response to abacavir, didanosine and tenofovir using quantitative real-time reverse transciptase PCR, FACS and ELISA. The assessed genes/proteins included the proinflammatory molecules VCAM-1, ICAM-1, MCP-1, RANTES and IL-6. In addition, we assessed the gene expression of the intracellular reactive oxygen producing NADPH oxidase subunit gp91 PHOX and the apoptosis regulating molecules Bcl-2 and BAD. Results: Exposure of HCAECs to abacavir, didanosine and tenofovir resulted in no statistically significant changes in any of the tested genes/proteins at any time point or at any concentration. Conclusions: We found no evidence that abacavir, didanosine or tenofovir had direct in vitro effects on coronary endothelial cell gene transcription and protein expression of the selected mediators. If abacavir or didanosine increase cardiovascular risk, it is likely not through the direct endothelial activation pathways tested in these experiments. However, further studies are needed to completely exclude the toxicity of abacavir or didanosine on endothelial cells.",
author = "Chul Kim and Samir Gupta and Linden Green and Taylor, {Brian M.} and Maja Deuter-Reinhard and Zeruesenay Desta and Matthias Clauss",
year = "2011",
doi = "10.3851/IMP1891",
language = "English",
volume = "16",
pages = "1335--1339",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press Ltd",
number = "8",

}

TY - JOUR

T1 - Abacavir, didanosine and tenofovir do not induce inflammatory, apoptotic or oxidative stress genes in coronary endothelial cells

AU - Kim, Chul

AU - Gupta, Samir

AU - Green, Linden

AU - Taylor, Brian M.

AU - Deuter-Reinhard, Maja

AU - Desta, Zeruesenay

AU - Clauss, Matthias

PY - 2011

Y1 - 2011

N2 - Background: The use of abacavir and didanosine in HAART has been associated with an increased risk of myocardial infarction in HIV-infected patients. The aim of this study was to address the development of endothelial dysfunction in cultivated coronary artery endothelial cells (HCAECs) in response to abacavir, didanosine and tenofovir. We examined the impact of these drugs on the expression levels of the proinflammatory, oxidative stress and apoptosis regulating genes in HCAECs. Methods: We tested gene and protein expression changes in HCAECs in response to abacavir, didanosine and tenofovir using quantitative real-time reverse transciptase PCR, FACS and ELISA. The assessed genes/proteins included the proinflammatory molecules VCAM-1, ICAM-1, MCP-1, RANTES and IL-6. In addition, we assessed the gene expression of the intracellular reactive oxygen producing NADPH oxidase subunit gp91 PHOX and the apoptosis regulating molecules Bcl-2 and BAD. Results: Exposure of HCAECs to abacavir, didanosine and tenofovir resulted in no statistically significant changes in any of the tested genes/proteins at any time point or at any concentration. Conclusions: We found no evidence that abacavir, didanosine or tenofovir had direct in vitro effects on coronary endothelial cell gene transcription and protein expression of the selected mediators. If abacavir or didanosine increase cardiovascular risk, it is likely not through the direct endothelial activation pathways tested in these experiments. However, further studies are needed to completely exclude the toxicity of abacavir or didanosine on endothelial cells.

AB - Background: The use of abacavir and didanosine in HAART has been associated with an increased risk of myocardial infarction in HIV-infected patients. The aim of this study was to address the development of endothelial dysfunction in cultivated coronary artery endothelial cells (HCAECs) in response to abacavir, didanosine and tenofovir. We examined the impact of these drugs on the expression levels of the proinflammatory, oxidative stress and apoptosis regulating genes in HCAECs. Methods: We tested gene and protein expression changes in HCAECs in response to abacavir, didanosine and tenofovir using quantitative real-time reverse transciptase PCR, FACS and ELISA. The assessed genes/proteins included the proinflammatory molecules VCAM-1, ICAM-1, MCP-1, RANTES and IL-6. In addition, we assessed the gene expression of the intracellular reactive oxygen producing NADPH oxidase subunit gp91 PHOX and the apoptosis regulating molecules Bcl-2 and BAD. Results: Exposure of HCAECs to abacavir, didanosine and tenofovir resulted in no statistically significant changes in any of the tested genes/proteins at any time point or at any concentration. Conclusions: We found no evidence that abacavir, didanosine or tenofovir had direct in vitro effects on coronary endothelial cell gene transcription and protein expression of the selected mediators. If abacavir or didanosine increase cardiovascular risk, it is likely not through the direct endothelial activation pathways tested in these experiments. However, further studies are needed to completely exclude the toxicity of abacavir or didanosine on endothelial cells.

UR - http://www.scopus.com/inward/record.url?scp=83455206897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83455206897&partnerID=8YFLogxK

U2 - 10.3851/IMP1891

DO - 10.3851/IMP1891

M3 - Article

C2 - 22155915

AN - SCOPUS:83455206897

VL - 16

SP - 1335

EP - 1339

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 8

ER -